SGN-CD123A - Seattle Genetics
Seattle Genetics: Cowen and Company Global Healthcare Conference (Seattle Genetics, Inc) - Mar 10, 2016 - Anticipated initiation of P1 trial in AML in 2016 
Anticipated new P1 trial • Acute Myelogenous Leukemia • Oncology
http://wsw.com/webcast/cowen30/sgen/
 
Mar 10, 2016
 
.